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Abstract
Background: Some smokeless tobacco products (SLT) have been shown to be associated with only a fraction of the risks of
cigarettes. This study assessed South African smokers’ interest in switching to a hypothetical reduced harm SLT product.
Methods: The 2007 South African Social Attitudes Survey was analysed for 678 exclusive cigarette smokers. Respondents
were asked about their perceptions about relative harm of snuff compared to cigarettes, and their interest in switching to
snuff if informed it was 99% less harmful than cigarettes.
Results: About 49.7% of exclusive cigarette smokers believed that snuff was equally as harmful as cigarettes; 12.9% thought
snuff was more harmful; 5.7% thought snuff was less harmful; while 31.8% did not know if there was a difference in harm
between snuff and cigarettes. Approximately 24.2% of exclusive cigarette smokers indicated interest in switching to snuff,
with significantly greater interest observed among those exposed to 100% smoke-free work environment. Interest in
switching was highest (34.7%) among smokers who believed a priori that using snuff was more harmful than cigarettes, and
lowest (14.5%) among those who did not know if there was a difference in harm. In a multi-variable adjusted logistic
regression model, this latter group remained less likely to be interested in harm reduction switching (adjusted odds
ratio=0.42; 95% CI: 0.19–0.91).
Conclusion: About a quarter of smokers indicated interest in harm reduction switching to snuff. SLT products have a
potential role in reducing the harm from smoking in South Africa, but only if they are not used to circumvent smoke-free
laws that have been associated with reduced smoking.
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Introduction
Smokeless tobacco (SLT) is a small category within the South
African tobacco market, with the majority of users being black
females of low socio-economic status. [1] Unlike India and several
Western countries where most SLT products are used orally (e.g.,
chewing tobacco and Swedish-style snus), most commercial and
traditional SLT products in South Africa are used nasally. A
recent study showed that the levels of carcinogenic tobacco-
specific nitrosamines in traditional South African SLT products
are up to 19 times higher than those in Swedish-style snus. [2]
Although low-nitrosamine, Swedish-style snus was introduced into
the South African SLT market in 2005 for situational use - ‘where
you can’t smoke’ and as a reduced risk product, [3] uptake of the
product has remained low in South Africa.
‘‘First, do no harm’’ remains one of the guiding principles in
medicine and public health. However, the definition of what
constitutes population-level ‘‘harm’’ regarding use of modified-risk
tobacco products remains controversial in the tobacco control
community. Proponents of harm reduction hold that it is
paternalistic and unethical for public health authorities to fail to
provide comprehensive information to smokers that SLT products
are relatively less harmful than cigarettes.[4–6] On the other hand,
the counter-argument is made that no tobacco product is safe, and
that it is harmful to promote a product that has significant
potential for addiction, abuse liability, and disease, including oral
cancer. [7,8] Hence the sale and use of SLT products has
remained banned in several regions including Australia and parts
of Europe. [9,10] Nonetheless, based on scientific evidence on
relatively lower content of tobacco carcinogens in certain SLT
products compared to combustible tobacco products, and also
evidence from countries such as Sweden where low-nitrosamine
snus has been widely used as a harm reduction strategy, the
potential role of SLT products in reducing smoking-attributable
morbidity and mortality must be acknowledged. [11,12] However,
this potential benefit of SLT can only be optimal in an
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minimum, with SLT being used in lieu of cigarettes and other
combustible tobacco products, rather than in dual fashion.
Similar to the United States, SLT manufacturers in South
Africa are required by law (since 1995) to include the phrase
‘‘causes cancer’’ on every can of SLT. [13] In recent years, some
have however maintained that such federally mandated warnings
on SLT products negate harm reduction messages, [14] and that
given correct information about the relative harm of SLT products
compared to cigarettes, smokers would be motivated towards
harm reduction switching. [4] Although Biener et al previously
showed that U.S. smokers’ interest in trying low-nitrosamine snus
was higher among those who correctly believed it was less harmful
than cigarettes, [15] other studies conducted mainly in developed
countries suggested that only about one-third or less of smokers
expressed interest in using SLT products. [16,17] Despite these
developments, very little information exists on the interest of
smokers from low and middle income countries in switching to
SLT if informed it is relatively less harmful than cigarettes. To fill
this gap in knowledge, this study used nationally representative
data from the 2007 South African Social Attitudes Survey
(SASAS) to assess smokers’ perceptions on relative harmfulness
of SLT and cigarettes, and their interest in harm reduction
switching to a hypothetical SLT product if informed it had only a
fraction of the risks of cigarettes.
Table 1. Characteristics of study population, South African Social Attitudes Survey, 2007 (n=2907).
Characteristics
Sample
%( n )
Current smoking prevalence
*n=689% (95% CI)
Current Snuffing prevalence
{n=119% (95% CI)
% of current exclusive cigarette
smokers
" interested in harm
reduction switching to snuff n=678
Race
Black African 76.7 (1812) 17.2 (14.8–19.5) 6.5 (4.8–8.2) 32.0 (24.9–39.1)
Colored 9.4 (434) 40.9 (33.2–48.7) –
1 9.3 (4.2–14.4)
Indian or Asian 2.7 (326) 27.6 (18.9–36.3) –
1 17.1 (6.6–27.7)
White 11.2 (335) 28.7 (21.9–35.6) –
1 12.0 (3.4–20.5)
Sex
Male 48.7 (1221) 33 (29.3–36.6) 1.4 (0.6–2.3) 27.7 (21.6–33.7)
Female 51.3 (1686) 9.5 (7.3–11.6) 8.4 (6.1–10.7) 12.8 (7.5–18.0)
Age, years
16–24 27.4 (686) 17.5 (13.6–21.4) 1.2 (0.2–2.2) 16.2 (8.1–24.2)
25–34 26.0 (633) 21.7 (17.4–26.1) 3.3 (1.6–5.0) 27.9 (18.4–37.4)
35–44 17.0 (614) 26.3 (20.9–31.8) 3.6 (0.9–6.3) 24.2 (13.7–34.7)
45–54 13.5 (440) 23.3 (17.3–29.3) 8.7 (5.0–12.4) 36.3 (20.3–52.4)
$55 16.2 (526) 17.8 (12.9–22.6) 12.7 (7.9–17.5) 17.2 (8.8–25.7)
Education
,12 year of schooling 61.9 (1798) 21.3 (18.5–24.1) 7.2 (5.2–9.2) 28.5 (21.5–35.4)
=12 year of schooling 28.2 (762) 20.5 (16.3–24.6) 1.1 (0.3–1.9) 13.0 (6.6–19.4)
.12 year of schooling 9.9 (336) 20.7 (14.3–27.0) 1.0 (0.1–2.1) 28.8 (13.6–44.1)
Marital Status
Never married 54.0 (1378) 20.8 (17.7–23.8) 2.8 (1.6–4.0) 24.1 (17.4–30.7)
Widowed, divorced, or
separated
12.3 (436) 21.4 (15.0–27.9) 14.7 (8.9–20.4) 18.0 (8.2–27.8)
Married 33.8 (1086) 21.2 (17.9–24.6) 5.2 (3.2–7.2) 26.7 (17.5–35.8)
Employment
Unemployed 32.6 (1037) 29.4 (25.1–33.7) 3.1 (1.8–4.5) 23.3 (15.8–30.8)
Pensioner/student/
housewife
44.0 (1177) 19.3 (16.1–22.6) 7.0 (5.0–9.0) 28.6 (20.4–36.8)
Employed 23.4 (680) 12.5 (8.9–16.1) 3.9 (1.3–6.6) 14.7 (4.5–24.9)
Region
Urban 67.5 (2011) 21.7 (18.8–24.5) 4.5 (2.9–6.1) 21.5 (15.5–27.5)
Rural 32.5 (896) 19.4 (15.9–22.9) 6.0 (3.6–8.4) 30.8 (22.2–39.3)
Overall 100.0 (2907) 20.9 (18.7–23.1) 5.0 (3.7–6.4) 24.2 (19.3–29.2)
Note: All samples (n) were unweighted while all percentages (%) were weighted to account for the complex survey design. CI=Confidence interval.
*Respondents who reported smoking hand-rolled or manufactured cigarettes daily or on some days.
{Respondents who reported using nasal or oral snuff daily or on some days.
1By race, virtually 100% of current snuffers were Black Africans.
"Exclusive cigarette smokers were defined as current smokers that did not report current use of oral or nasal snuff.
doi:10.1371/journal.pone.0095553.t001
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Survey Design/sample
The SASAS is a household survey which uses a multi-stage
probability sampling strategy with census enumeration areas as the
primary sampling unit. The original protocols for the SASAS were
approved by the South African Human Sciences Research
Council (HSRC). In 2007, a sample of 3500 households was
drawn from the master sample of the HSRC. This SASAS sample
was stratified by socio-demographic domain for each province and
geographical subtypes, namely tribal areas, formal rural, formal
urban and informal urban. This stratification is designed to ensure
sufficient geographical distribution across all nine provinces, and
adequate distribution between South Africa’s four race groups.
From each of the households, one eligible person ($16 years old)
was randomly selected for participation in the survey. [18] In
2007, the pre-tested survey questionnaires were administered by
trained interviewers in the respondents’ preferred language, which
was selected from among all eleven South African official
languages (questionnaires were available in all official languages).
The survey was completed by 2907 respondents, yielding an
overall response rate of 83.1%.
This study was performed on de-identified secondary data.
These data are deposited with the HSRC. While the tobacco use
supplement of the SASAS is not publicly available, the data can
however be obtained upon special request through the HSRC or
its primary collaborator–the University of Pretoria.
Measures
Socio-demographic characteristics. Socio-demographic
characteristics assessed included race (Black African; Colored;
Indian or Asian; or White); sex (male or female); age (16–24; 25–
34; 35–44; 45–54 or $55 years), educational attainment (,
12;=12; or .12 years of schooling), marital status (single;
married; or widowed/divorced/separated); employment status
(unemployed; pensioner/housewife/student; or employed) and
region (urban or rural).
Tobacco use. Current cigarette smokers were respondents
who reported smoking roll-your-own cigarettes or factory-made
cigarettes daily or on some days. Current snuff users were
respondents who reported using nasal or oral snuff daily or on
some days. Data were also collected among smokers on lifetime
duration of smoking, number of cigarettes smoked per day (CPD)
(1–10; 11–20; 21–30; or .30 cigarettes) and the time from waking
up to smoking first cigarette (#5, 6–30, 31–60, or .60 minutes).
We also measured smoking restrictions in the home and work
environments.
Lifetime quit attempts and quit intentions. A lifetime quit
attempt among current smokers was defined as any response of
‘‘once’’, ‘‘twice’’, ‘‘three times or more’’ to the question: ‘‘Have
you ever tried to quit smoking?’’.
Among current smokers that had made a past quit attempt,
methods employed to quit smoking were assessed and included:
cold turkey (i.e., just stopped smoking one day without using any
smoking cessation aids), cutting-down, use of nicotine replacement
therapy (e.g. patch, gum) or prescription medication (e.g. Zyban),
or switching to light cigarettes, snuff or snus.
A quit intention was defined as any response of ‘‘within the next
month’’, within the next 6 months’’, or ‘‘sometime in the future,
beyond 6 months’’ to the question: ‘‘Are you planning to quit
smoking?’’ Smokers’ self-efficacy about successfully giving up
smoking if they were to try quitting in the next six months was
measured on a four-point of ‘‘Very likely’’; ‘‘Fairly likely’’; ‘‘Not
very likely’’; or ‘‘Not at all likely’’.
Reasons for smoking and for past quit
attempts. Considering that reasons for smoking may influence
the level of interest in switching to snuff, smokers were asked
reasons why they smoked, which were then categorized into four
themes namely; 1) for enjoyment or relaxation; 2) for concentra-
tion or coping with daily life; 3) difficulty quitting or lack of
willpower to try; and 4) social influences (i.e., helps smoker feel
confident around others; perception that smoking is a normal
thing to do; or the perception that smoking helps to keep weight
down).
Smokers who had made a past quit attempt were also asked
what factors motivated them, which were then categorized into six
themes namely: 1) cost of smoking; 2) smoking-related health
problems or concern for the health of household members; 3)
motivation from family and friends; 4) changing social environ-
ment towards smoking (i.e., proliferation of smoke-free laws and
societal denormalization of smoking); 5) advice from a healthcare
professional and; 6) reaction to cigarette health warning labels.
Perception about relative harm of snuff compared to
cigarettes. Perception about the relative harm of snuff and
cigarettes was assessed using the question: ‘‘Do you believe that
snuff is a safer alternative to smoking cigarettes?’’ Categorical
responses included: ‘‘Using snuff is safer than smoking’’, ‘‘Using
snuff is equally as harmful as smoking’’, ‘‘Using snuff is more
harmful than smoking’’, and ‘‘Do not know’’.
Interest in switching to snuff. Interest in harm reduction
switching to snuff was assessed with the question: ‘‘If you currently
smoke and were told that snuff is 99% safer than smoking and it
would give you the same amount of nicotine you crave from your
cigarette, how likely would you be to switch?’’ Responses of ‘‘Very
likely’’ or ‘‘Somewhat likely’’ were categorized together as an
affirmative response, while responses of ‘‘Somewhat unlikely’’ or
‘‘Very unlikely’’ were categorized together as a dissenting
response.
It is pertinent to note that the survey first asked current smokers
about their knowledge of the relative harm of snuff and cigarettes
earlier on in the survey and then later asked if they would be
interested in switching to snuff if they were told it was 99% safer
than cigarettes. Pre-testing of the questionnaire used showed that
keeping the phrase ‘99% safer’ also conveyed a local layman’s
lingua of ‘confidently’ or ‘surely’, or ‘certainly’ safer.
Statistical Analysis
Prevalence of current smoking and SLT use were calculated
overall and by socio-demographic variables. Comparison of
estimates was performed using x
2 tests (p,0.05).
Level of nicotine dependence among current smokers was
assessed using the Heaviness of Smoking Index- a six-point scale
calculated from CPD and the time to first cigarette after waking.
[19] Scores of 0–1 were categorized as low nicotine dependence;
2–4 as moderate nicotine dependence; and 5–6 as high nicotine
dependence. For the purposes of these analyses, moderate
(n=409) and high (n=15) nicotine dependent smokers were
analyzed together as one category because of the small sample
among the latter.
The primary analysis which assessed smokers’ interest in
switching to snuff if informed that snuff was 99% less harmful
than cigarettes, was restricted to exclusive cigarette smokers,
defined as current smokers who did not report using oral or nasal
snuff. However, in a secondary analysis, we also explored the role
of snuff in modifying cigarette smoking behavior, by comparing
CPD and quit attempts between exclusive cigarette smokers and
dual users of cigarettes and snuff.
Harm Reduction Switching to Smokeless Tobacco
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exclusive smokers’ interest in harm reduction switching, we fitted
a multivariate logistic regression model that assessed for presence
of smoke-free homes and workplaces, reasons for smoking,
heaviness of smoking, lifetime duration of smoking, perceptions
about relative harm of snuff and cigarettes, past quit attempts, self-
efficacy towards quitting, race, sex, age and education (p,0.05).
Data were weighted using the ‘‘svyset’’ function in STATA 11 to
account for the complex survey design characteristics, and also
included the ‘‘psu’’ and ‘‘strata’’ options since the population was
sampled by stratifying it first and then randomly selecting several
clusters for each stratum.
Table 2. Tobacco use, quit attempts and perceptions of current exclusive cigarette smokers, South African Social Attitudes Survey,
2007.
Characteristic
Overall *n=678
Estimate (95% CI)
Males n=451
Estimate (95% CI)
Females n=227
Estimate (95% CI)
Smoking characteristics among all current exclusive cigarette
smokers (n=678)
Mean number of cigarettes smoked per day, cigarette sticks 9.5 (8.6–10.4) 9.1 (8.1–10.2) 10.6 (8.8–12.3)
Mean duration of smoking, years 13.4 (12.1–14.8) 13.0 (11.5–14.5) 14.9 (11.9–17.9)
Reasons for smoking, %
For enjoyment or relaxation 74.0 (69.4–78.6) 73.1 (67.6–78.5) 77.2 (68.7–85.7)
For concentration or to cope with daily life 29.2 (24.2–34.2) 29.4 (23.7–35.0) 28.5 (18.7–38.2)
Difficulty quitting or lack of willpower to try 32.4 (26.8–38.0) 31.5 (24.8–38.2) 35.3 (25.9–44.6)
Social influences 20.0 (15.6–24.4) 18.9 (14.0–23.7) 24.0 (16.0–32.1)
Past Quit attempts among current exclusive cigarette smokers that had
ever made a quit attempt (n=402)
% of current smokers that had ever made a quit attempt 59.4 (53.6–65.3) 59.6 (52.6–66.6) 59.0 (48.9–69.0)
Number of past quit attempts, %
1 41.8 (34.0–49.6) 45.1 (35.9–54.4) 31.0 (20.4–41.4)
2 20.6 (15.5–25.7) 20.2 (14.1–26.2) 22.0 (12.9–31.0)
3+ 37.6 (30.6–44.6) 34.7 (26.5–42.9) 47.1 (36.3–57.8)
Method used in past quit attempts, %
Cold turkey (i.e., just stopped smoking one day) 22.5 (16.9–28.1) 20.9 (14.3–27.5) 27.4 (16.8–38.0)
Cutting down 59.7 (52.7–66.7) 62.0 (53.5–70.5) 52.7 (42.1–63.3)
Switching to light cigarettes or smokeless tobacco 9.4 (4.7–14.0) 8.7 (3.0–14.5) 11.3 (4.0–18.6)
Counseling or pharmacotherapy
{ 8.4 (4.4–12.4) 8.3 (3.6–13.1) 8.6 (1.1–16.0)
Reasons for past quit attempts, %
Cost of smoking 44.3 (36.4–52.2) 41.3 (32.0–50.5) 54.5 (41.0–68.3)
Health concerns 70.0 (63.2–76.8) 65.7 (57.6–73.9) 84.6 (77.2–92.0)
Motivation from family and friends 12.8 (7.8–17.7) 13.8 (7.7–19.9) 9.2 (3.9–14.4)
Changing social environment towards smoking 13.9 (8.1–19.7) 13.7 (6.9–20.5) 14.6 (3.6–25.6)
Advice from a healthcare professional 5.5 (2.5–8.4) 4.8 (1.4–8.2) 7.9 (2.1–13.7)
Reaction to cigarette health warning label 5.0 (2.0–8.0) 5.5 (1.8–9.3) 3.1 (0.1–6.5)
Quit intentions among all current exclusive cigarette smokers (n=678)
% with quit intentions 52.8 (46.5–59.1) 50.9 (43.6–58.3) 59.3 (47.8–70.9)
% of those intending to quit who felt confident of at least a
fair chance at success if they tried quitting in the next 6 months
1
62.0 (54.9–69.1) 62.5 (51.7–73.3) 62.0 (52.3–71.7)
Perceptions about relative harm of tobacco products among
all current exclusive cigarette smokers (n=678)
Perception of the relative harm of snuff compared to cigarettes, %
Using snuff is safer than smoking 5.7 (3.4–8.0) 5.6 (2.9–8.3) 6.2 (2.0–10.4)
Using snuff is as equally harmful as smoking 49.7 (44.1–55.2) 51.7 (45.0–58.4) 42.8 (33.9–51.7)
Using snuff is more harmful than smoking 12.9 (9.5–16.2) 12.1 (8.3–15.9) 15.5 (8.2–22.8)
Did not know 31.8 (26.4–37.1) 30.7 (24.3–37.0) 35.5 (26.8–44.3)
Note: All samples (n) were unweighted while all percentages (%) were weighted to account for the complex survey design. CI=Confidence interval.
*Some totals may add up to over 100% because multiple responses were allowed.
{Counseling included individual and group counseling sessions, including those by a faith/religious or traditional healer. Pharmacotherapy included use of nicotine
replacement therapy (e.g. patch, gum) as well as prescription medication (e.g. Zyban).
1Respondents who thought they were ‘‘fairly likely’’ or ‘‘very likely’’ at being successful at quitting if they attempted within the next 6 months.
doi:10.1371/journal.pone.0095553.t002
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Tobacco Use, Past Quit Attempts and Quit Intentions
Demographic characteristics are shown in Table 1. Overall
current smoking prevalence was 20.9% (n=689) while the
prevalence of current snuff use was 5.0% (n=119). Of the current
smokers, 97.6% (n=678) exclusively smoked cigarettes, with an
average duration of smoking of 13.4 years. About 59.4% (n=402)
of exclusive cigarette smokers had made a lifetime quit attempt,
and of these, 9.4% had tried to quit cigarette smoking by switching
to light cigarettes or snuff (Table 2). Among smokers that had
made a quit attempt, about 70.0% did so because of concerns
about health risks of smoking to themselves or their family
members.
There were no significant difference observed in the proportion
of past-quit-attempters between exclusive cigarette smokers
(59.4%) and dual users of cigarettes and snuff (68.5%). Similarly,
the average CPD among exclusive cigarette smokers (mean=9.5;
standard deviation=9.1) did not vary significantly from dual users
of cigarettes and snuff (mean=8.4; standard deviation=5.6).
Perception about Relative Harm of Snuff Compared to
Cigarettes
The proportion of respondents who believed that using snuff is
equally as harmful as smoking cigarettes was significantly higher
among exclusive cigarette smokers (49.7%) compared to snuffers
(21.8%) (p,0.05). In contrast, the proportion that believed that
using snuff is safer than smoking was significantly lower among
exclusive cigarette smokers (5.7%) compared to snuffers (67.5%)
(p,0.05). Also, 31.8% of exclusive cigarette smokers versus 2.7%
of snuffers reported not knowing if there was a difference in harm
between snuff and cigarettes (p,0.05). No significant smoker-
snuffer difference was observed in the proportion who believed
that snuff is more dangerous than cigarettes (12.9% vs. 8.0%
respectively; Table 3).
Interest in Harm Reduction Switching
About 24.2% of all exclusive cigarette smokers indicated interest
in harm reduction switching to snuff. This proportion was highest
(34.7%) among exclusive cigarette smokers who believed a priori
that snuff is more harmful than cigarettes, and lowest (14.5%)
among those who did not know if there was a difference in harm
between snuff and cigarettes. After adjusting for all other factors,
this latter group remained less likely to be interested in harm
reduction switching (adjusted odds ratio [aOR]=0.42; 95%
confidence interval [CI]: 0.19–0.91). Other factors associated
with interest in harm reduction switching included: presence of
100% smoke-free policies at work (aOR=2.05; 95%CI: 1.09–
3.97); increasing self-efficacy towards successfully quitting
(aOR=1.49; 95%CI: 1.21–1.84) and smoking cigarettes primarily
to enhance concentration or cope with everyday life (aOR=1.58;
95%CI: 1.02–2.46). History of at least one past quit attempt was
associated with lowered interest in switching to snuff (aOR=0.58;
95%CI: 0.35–0.95) (Table 4).
Discussion
Similar to findings in the literature, [20] this study demonstrated
that about a quarter of exclusive cigarette smokers indicated
interest in harm reduction switching to SLT products. The fact
that only a relatively small fraction of smokers were interested in
harm reduction switching may attest to the fact that while nicotine
is the primary addictive agent in tobacco, the role of smoking
sensory experience (e.g., taste, flavor, and mouth-feel of tobacco
smoke), as well as behavioral addictions (e.g., the hand-to-mouth
motions of smoking) as secondary reinforcers of smoking behavior
cannot be under-estimated. Thus, a lack of interest among
smokers in switching to SLT products may not necessarily indicate
a lack of awareness about the risks of smoking. For example,
among smokers that had made a quit attempt, 70% had done so
out of concern for smoking related health problems, indicating
that ignorance about the health risks of smoking is not likely an
issue among this population. Taken together, this might suggest
that promotion of snuff use among this predominant group of
smokers not interested in harm reduction switching may only
encourage dual use of cigarettes and SLT (i.e. using SLT only
where smoking is not allowed), which might cause net population
harm, especially if it reduces the impact of smoke-free laws in
promoting tobacco cessation. [8] This is particularly pertinent in
the studied population considering that a significantly higher
Table 3. Comparative risk perception between non users of tobacco, current cigarette smokers and current snuffers, South African
Social Attitudes Survey, 2007.
Perception
Non-tobacco users
*n=1991% (95% CI)
Current exclusive
cigarette smokers
{n=678% (95% CI)
Current snuffers
1n=119% (95% CI)
% of exclusive cigarette smokers interested in
switching to snuff if informed it was 99% safer than
cigarettes and yielded the same amount of nicotine
as cigarettes (95% CI)
Using snuff is safer
than smoking
11.9 (9.7–14.2) 5.7 (3.4–8.0) 67.5 (56.4–78.5) 26.2 (9.1–43.3)
Using snuff is as
equally harmful
as smoking
48.5 (44.9–52.1) 49.7 (44.1–55.2) 21.8 (11.8–31.7) 27.7 (19.6–35.8)
Using snuff is more
harmful than
smoking
10.0 (8.0–11.9) 12.9 (9.5–16.2) 8 (0.3–15.8) 34.7 (21.9–47.5)
Did not know 29.6 (26.3–33.0) 31.8 (26.4–37.1) 2.7 (0.0–5.7) 14.5 (7.8–21.2)
Note: All samples (n) were unweighted while all percentages (%) were weighted to account for the complex survey design. CI=Confidence interval.
*Respondents that had never used any of the following tobacco products during their lifetime: manufactured cigarettes, hand-rolled cigarettes, pipes or cigars or
smokeless tobacco products (including nasal or oral snuff).
{Respondents who reported smoking roll-your-own cigarettes or factory-made cigarette daily or some days, but who were not current users of oral or nasal snuff.
1Respondents who reported using oral or nasal snuff daily or some days.
doi:10.1371/journal.pone.0095553.t003
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Characteristic Categories
Crude odds ratios,
95% CI
Adjusted odds ratios,
95% CI
Smoke-free environments
Smoke-free home regulations Absent (Referent)
Present 1.60 (1.12–2.29) 1.35 (0.83–2.20)
Smoke-free policies at work No smoke-free policy at work (Referent)
Partial bans on workplace smoking 1.24 (0.72–2.14) 1.30 (0.65–2.59)
100% smoke-free policies at work 2.14 (1.35–3.39) 2.05 (1.09–3.87)
*
Did not know/did not answer 0.71 (0.38–1.34) 1.14 (0.52–2.49)
Self-reported reasons for Smoking
For pleasure or enjoyment (i.e., hedonistic reward) No (Referent)
Yes 0.43 (0.27–0.69) 0.67 (0.38–1.17)
To enhance concentration or cope with everyday life No (Referent)
Yes 1.74 (1.19–2.54) 1.58 (1.02–2.46)
*
Difficulty quitting or lack of willpower to try No (Referent)
Yes 0.66 (0.45–0.98) 1.20 (0.74–1.93)
Social influences
{ No (Referent)
Yes 0.84 (0.53–1.33) 0.79 (0.46–1.34)
Tobacco use characteristics and perception
Heaviness of smoking index Low dependence (Referent)
Moderate to heavy dependence 0.62 (0.43–0.91) 0.76 (0.48–1.21)
Duration of smoking, years (Per unit increase) 1.00 (0.98–1.02) 1.02 (0.99–1.05)
Perception of relative harm from snuff use Snuff is safer than smoking (Referent)
Snuff equally harmful as smoking 0.76 (0.40–1.44) 0.64 (0.31–1.32)
Snuff more harmful than smoking 1.00 (0.49–2.06) 1.04 (0.43–2.52)
Did not know 0.39 (0.20–0.76) 0.42 (0.19–0.91)
*
Lifetime Quit attempts
Past quit attempt None (Referent)
$1 0.79 (0.55–1.13) 0.58 (0.35–0.95)
*
Number of past quit attempts
(among past quit attempters)
1 (Referent)
2 0.51 (0.20–1.28) 0.47 (0.18–1.20)
$3 0.33 (0.14–0.75) 0.30 (0.12–0.71)
Self efficacy to quit
" (Per unit increase) 1.43 (1.20–1.70) 1.49 (1.21–1.84)
*
Socio-demographic characteristics
Race Black African (Referent)
Colored 0.38 (0.22–0.64) 0.48 (0.23–1.02)
Indian or Asian 0.39 (0.21–0.72) 0.59 (0.28–1.27)
White 0.30 (0.15–0.59) 0.57 (0.22–1.43)
Gender Male (Referent)
Female 0.54 (0.36–0.80) 0.75 (0.43–1.30)
Age, years 16–24 (Referent)
25–34 1.29 (0.75–2.20) 1.59 (0.80–3.19)
35–44 0.94 (0.53–1.66) 1.10 (0.51–2.39)
45–54 1.39 (0.78–2.48) 1.67 (0.73–3.83)
$55 1.01 (0.56–1.82) 1.00 (0.34–2.95)
Education ,12 year of schooling (Referent)
=12 year of schooling 0.58 (0.36–0.93) 0.57 (0.31–1.03)
.12 year of schooling 0.69 (0.36–1.33) 0.69 (0.33–1.47)
Note: All analyses were weighted to account for the complex survey design. CI=Confidence interval.
*Statistical significant after adjusting for all other factors listed in table (P,0.05).
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policies at work indicated interest in harm reduction switching.
The likelihood of harm reduction switching was significantly
lower among current exclusive smokers that had made a quit
attempt, and further reduced with the number of past quit
attempts. In other words, the use of SLT as a substitute to smoking
seemed to be attractive to those who might be considered
inveterate smokers. Indeed, previous studies have suggested that
interest in SLT was greater among smokers who were unwilling to
make a quit attempt, [21] or were not planning to quit smoking.
[16] The observation of those that had made multiple quit
attempts not being interested in switching may suggest that these
past quit-attempters may be more interested in attaining and
maintaining a tobacco-free status rather than harm reduction
switching to another tobacco product. This may also explain why
the use of snuff or ‘‘light cigarettes’’ as a smoking cessation aid was
also relatively unpopular among smokers that had made a past
quit attempt (9.4%). Even among smokers that had successfully
quit smoking (i.e., former smokers, n=75), only 5.4% had ever
used snuff, while the majority had done so using ‘cold turkey’ (data
not shown). These findings are corroborated from a recent study
among Nigerian male smokers which showed no significant
difference in smoking intensity among exclusive cigarette smokers
when compared to current smokers that also used snuff, indicating
that snuff use was not associated with reduced harm among
continuing smokers who had tried snuff. [22] The fact that
exclusive smokers in our study who expressed greater self-
confidence in quitting were also more likely to express a greater
interest in switching indicates that smokers’ self-efficacy at baseline
is a potential confounder that should be controlled for in future
studies on the effect of snuff on quitting smoking.
It is pertinent to note that the majority of snuff users (67.5%),
although exposed to the same health warnings as cigarette
smokers, were more likely to believe that snuff was less harmful
than cigarettes. This suggests that the observed differences in belief
by tobacco use status might partly reflect a social judgment rather
than a true perceived relative risk. It is conceivable that users of a
particular product that is considered socially undesirable may want
to justify continued use by believing their product to be no more
harmful than another. The alternative explanation though is that
snuff users use it because they correctly believe it to be safer than
cigarette smoking. The cost savings on switching to SLT products
may be a further incentive, especially for price-sensitive smokers,
as traditional SLT products in South Africa are about six times
cheaper than premium brand cigarettes ($0.50 for 20 g SLT, vs. $3
for a pack of 20 cigarettes). However, this relatively lower cost of
SLT products could also be an incentive for young never tobacco
users to initiate tobacco use.
While the question posed to respondents asked them to assume
that the hypothetical SLT product was 99% safer than cigarettes,
this may be an oversimplification of the reality of the relative harm
of SLT products. Although the body of scientific evidence shows
that SLT products contain relatively lower levels of nitrosamines
and other toxins compared to combustible tobacco products, this
in no way implies that SLT products are harmless or a safe
alternative to cigarettes, especially so for the traditional products
that are more affordable in low and middle income countries. [2]
SLT use has been associated with several malignancies including
oral and esophageal cancers. [23] More so, given that several
multi-national cigarette companies have invested significantly in
SLT manufacture and several cigarette-branded SLT products are
available, [24] the potential of the tobacco industry promoting
dual use rather smoking cessation needs to be given consideration.
This is important considering that dual use among current
cigarette smokers is a significant public health problem, with over
a fifth of cigarette smokers in 28 of 44 countries assessed in a
recent study reporting concurrent use of at least one other non-
cigarette tobacco product. [25] Interestingly, our study showed
that while Colored respondents (i.e. those of mixed ancestry) as
well as Whites had the highest smoking prevalence, they
paradoxically had the lowest proportion indicating interest in
harm reduction switching to snuff. This may suggest that the
Swedish experience may not be transferrable to societies without a
strong SLT culture or those with unique tobacco use habits or
patterns. [3].
This study has some limitations. First, we did not make a
distinction as to the application route of this hypothetical reduced
harm SLT product. However, given that the aim was to explore
the interest of South African smokers in switching to a
considerably less harmful product and considering that the level
of interest in harm reduction switching in this study was
comparable to that reported in similar studies elsewhere; [20] it
is likely that the conclusions reached in this study will not differ
even if the route of application had been specified. Second, self-
reported tobacco use status and the cross-sectional study design
may have resulted in a mis-reporting of tobacco use and may also
preclude drawing causal inferences. Third, the fact that smokers
expressed interest in switching to snuff does not necessarily mean
they may actually switch–especially inveterate smokers or heavy
smokers–considering the interplay between neurobiological and
behavioral factors in smoking addiction. Fourth, it is possible that
the phrasing of our survey question which suggested complete
switching to cigarettes may not capture smokers who may not wish
to switch completely, but rather be interested in SLT only to
reduce their smoking intensity. Finally, since data were collected in
2007, it is possible that smokers’ views or perceptions may have
changed.
Conclusion
This study demonstrated that about a quarter of South African
exclusive cigarette smokers sampled in a 2007 population-based
survey indicated interest in harm reduction switching to snuff.
SLT products have a potential role in reducing the harm from
cigarettes smoking but only if they are not used to circumvent
smoke-free laws that have been associated with significant
reductions in smoking prevalence.
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